Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / COM
-
Number of holders
-
97
-
Total 13F shares, excl. options
-
21,330,780
-
Shares change
-
+3,424,548
-
Total reported value, excl. options
-
$263,216,123
-
Value change
-
+$41,105,981
-
Put/Call ratio
-
534%
-
Number of buys
-
66
-
Number of sells
-
-31
-
Price
-
$12.34
Significant Holders of BELLICUM PHARMACEUTICALS INC - COM (BLCM) as of Q1 2017
113 filings reported holding BLCM - BELLICUM PHARMACEUTICALS INC - COM as of Q1 2017.
BELLICUM PHARMACEUTICALS INC - COM (BLCM) has 97 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 21,330,780 shares
.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (5,032,313 shares), FMR LLC (2,858,677 shares), JPMORGAN CHASE & CO (2,239,084 shares), BlackRock Inc. (1,670,756 shares), VANGUARD GROUP INC (1,061,582 shares), Foresite Capital Management III, LLC (918,000 shares), FRANKLIN RESOURCES INC (651,800 shares), KENNEDY CAPITAL MANAGEMENT, INC. (632,065 shares), PRICE T ROWE ASSOCIATES INC /MD/ (555,298 shares), and MORGAN STANLEY (374,615 shares).
This table shows the top 97 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.